OR4F17
gene geneOn this page
Summary
OR4F17 (olfactory receptor family 4 subfamily F member 17, HGNC:15381) is a protein-coding gene on chromosome 19p13.3, encoding Olfactory receptor 4F17 (Q8NGA8). Odorant receptor. It is a selective cancer dependency (DepMap: 80.0% of cell lines).
Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome.
Source: NCBI Gene 81099 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 57 total
- Cancer dependency (DepMap): dependent in 80.0% of screened cell lines
- MANE Select transcript:
NM_001005240
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:15381 |
| Approved symbol | OR4F17 |
| Name | olfactory receptor family 4 subfamily F member 17 |
| Location | 19p13.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000176695 |
| Ensembl biotype | protein_coding |
| Entrez | 81099 |
Gene structure
Transcript identifiers
Ensembl transcripts: 4 — 3 protein_coding, 1 protein_coding_CDS_not_defined
ENST00000318050, ENST00000585993, ENST00000618231, ENST00000641591
RefSeq mRNA: 2 — MANE Select: NM_001005240
NM_001005240, NM_001429985
CCDS: CCDS32854
Canonical transcript exons
ENST00000585993 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002825729 | 107473 | 107555 |
| ENSE00002973945 | 110625 | 113156 |
| ENSE00003819007 | 107104 | 107157 |
Expression profiles
Bgee: expression breadth broad, 86 present calls, max score 98.36.
Top tissues by expression
111 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| colonic epithelium | UBERON:0000397 | 98.36 | gold quality |
| bone marrow cell | CL:0002092 | 94.22 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 92.17 | gold quality |
| sural nerve | UBERON:0015488 | 72.91 | gold quality |
| tonsil | UBERON:0002372 | 72.36 | gold quality |
| stromal cell of endometrium | CL:0002255 | 64.53 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 64.34 | gold quality |
| bone marrow | UBERON:0002371 | 63.68 | gold quality |
| cortical plate | UBERON:0005343 | 63.47 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 57.96 | gold quality |
| muscle tissue | UBERON:0002385 | 55.66 | gold quality |
| urinary bladder | UBERON:0001255 | 51.26 | gold quality |
| ganglionic eminence | UBERON:0004023 | 48.94 | gold quality |
| uterine cervix | UBERON:0000002 | 48.25 | gold quality |
| ventricular zone | UBERON:0003053 | 45.94 | gold quality |
| liver | UBERON:0002107 | 45.44 | gold quality |
| adrenal tissue | UBERON:0018303 | 42.71 | gold quality |
| skin of abdomen | UBERON:0001416 | 41.77 | gold quality |
| kidney | UBERON:0002113 | 40.30 | gold quality |
| zone of skin | UBERON:0000014 | 39.81 | gold quality |
| prefrontal cortex | UBERON:0000451 | 38.82 | gold quality |
| primary visual cortex | UBERON:0002436 | 38.78 | gold quality |
| mucosa of stomach | UBERON:0001199 | 38.28 | silver quality |
| leukocyte | CL:0000738 | 38.25 | silver quality |
| skin of leg | UBERON:0001511 | 37.67 | gold quality |
| monocyte | CL:0000576 | 37.37 | silver quality |
| ectocervix | UBERON:0012249 | 37.35 | gold quality |
| blood | UBERON:0000178 | 36.48 | gold quality |
| gall bladder | UBERON:0002110 | 36.04 | gold quality |
| granulocyte | CL:0000094 | 35.23 | gold quality |
Single-cell (SCXA)
Detected in 4 experiment(s), a significant marker in 2.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-7249 | yes | 73.44 |
| E-ANND-3 | yes | 3.12 |
| E-ENAD-27 | no | 113.42 |
| E-MTAB-6379 | no | 58.16 |
Regulation
Is transcription factor: no
Functional genomics
DepMap (CRISPR cell-line fitness): dependent in 80.0% of screened cell lines.
Cross-species orthologs
6 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Or4f4b | ENSMUSG00000061195 |
| mus_musculus | Or4f4-ps1 | ENSMUSG00000108891 |
| mus_musculus | Or4f17 | ENSMUSG00000108908 |
| rattus_norvegicus | Or4f4b | ENSRNOG00000079002 |
| rattus_norvegicus | ENSRNOG00000080423 | |
| rattus_norvegicus | ENSRNOG00000086124 |
Paralogs (130): OR1I1 (ENSG00000094661), OR12D3 (ENSG00000112462), OR7A10 (ENSG00000127515), OR7C2 (ENSG00000127529), OR7C1 (ENSG00000127530), OR1E2 (ENSG00000127780), OR1J1 (ENSG00000136834), OR1L4 (ENSG00000136939), OR4D1 (ENSG00000141194), OR4K1 (ENSG00000155249), OR3A3 (ENSG00000159961), OR7G1 (ENSG00000161807), OR1Q1 (ENSG00000165202), OR1K1 (ENSG00000165204), OR4K2 (ENSG00000165762), OR4D6 (ENSG00000166884), OR1F1 (ENSG00000168124), OR4K14 (ENSG00000169484), OR4K15 (ENSG00000169488), OR7G3 (ENSG00000170920), OR7G2 (ENSG00000170923), OR1M1 (ENSG00000170929), OR4D5 (ENSG00000171014), OR1L6 (ENSG00000171459), OR1L3 (ENSG00000171481), OR1L8 (ENSG00000171496), OR1N2 (ENSG00000171501), OR1N1 (ENSG00000171505), OR2AT4 (ENSG00000171561), OR1A1 (ENSG00000172146), OR1A2 (ENSG00000172150), OR4C11 (ENSG00000172188), OR4X2 (ENSG00000172208), OR4D9 (ENSG00000172742), OR10K1 (ENSG00000173285), OR1L1 (ENSG00000173679), OR7D4 (ENSG00000174667), OR4S2 (ENSG00000174982), OR4B1 (ENSG00000175619), OR4D11 (ENSG00000176200)
Protein
Protein identifiers
Olfactory receptor 4F17 — Q8NGA8 (reviewed: Q8NGA8)
Alternative names: Olfactory receptor 4F11, Olfactory receptor 4F18, Olfactory receptor 4F19
All UniProt accessions (3): Q8NGA8, A0A126GWN0, A0A2U3U062
UniProt curated annotations — full annotation on UniProt →
Function. Odorant receptor.
Subcellular location. Cell membrane.
Similarity. Belongs to the G-protein coupled receptor 1 family.
RefSeq proteins (2): NP_001005240, NP_001416914 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000276 | GPCR_Rhodpsn | Family |
| IPR000725 | Olfact_rcpt | Family |
| IPR017452 | GPCR_Rhodpsn_7TM | Domain |
| IPR050427 | Olfactory_Receptors | Family |
Pfam: PF13853
UniProt features (17 total): topological domain 8, transmembrane region 7, chain 1, disulfide bond 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8NGA8-F1 | 89.21 | 0.60 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Disulfide bonds (1): 90–182
Function
Pathways and Gene Ontology
Reactome pathways
2 pathways
| ID | Pathway |
|---|---|
| R-HSA-381753 | Olfactory Signaling Pathway |
| R-HSA-9752946 | Expression and translocation of olfactory receptors |
MSigDB gene sets: 16 (showing top):
GOBP_SENSORY_PERCEPTION_OF_CHEMICAL_STIMULUS, KEGG_OLFACTORY_TRANSDUCTION, GOBP_DETECTION_OF_STIMULUS, GOBP_SENSORY_PERCEPTION, chr19p13, GOMF_OLFACTORY_RECEPTOR_ACTIVITY, GOMF_TRANSMEMBRANE_SIGNALING_RECEPTOR_ACTIVITY, GOMF_G_PROTEIN_COUPLED_RECEPTOR_ACTIVITY, GOBP_SENSORY_PERCEPTION_OF_SMELL, GOBP_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY, GOBP_DETECTION_OF_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION, REACTOME_OLFACTORY_SIGNALING_PATHWAY, REACTOME_SENSORY_PERCEPTION, GOBP_DETECTION_OF_CHEMICAL_STIMULUS, GOMF_MOLECULAR_TRANSDUCER_ACTIVITY
GO Biological Process (4): signal transduction (GO:0007165), G protein-coupled receptor signaling pathway (GO:0007186), sensory perception of smell (GO:0007608), detection of chemical stimulus involved in sensory perception of smell (GO:0050911)
GO Molecular Function (2): G protein-coupled receptor activity (GO:0004930), olfactory receptor activity (GO:0004984)
GO Cellular Component (2): plasma membrane (GO:0005886), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-2 pathways:
| Category | Pathways |
|---|---|
| Sensory Perception | 1 |
| Olfactory Signaling Pathway | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| transmembrane signaling receptor activity | 2 |
| cell communication | 1 |
| cellular process | 1 |
| signaling | 1 |
| regulation of cellular process | 1 |
| cellular response to stimulus | 1 |
| G protein-coupled receptor activity | 1 |
| signal transduction | 1 |
| sensory perception of chemical stimulus | 1 |
| sensory perception of smell | 1 |
| detection of chemical stimulus involved in sensory perception | 1 |
| G protein-coupled receptor signaling pathway | 1 |
| detection of chemical stimulus involved in sensory perception of smell | 1 |
| membrane | 1 |
| cell periphery | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
104 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| OR4F17 | MBD3L4 | A6NDZ8 | 610 |
| OR4F17 | GOLGA8CP | A6NN73 | 593 |
| OR4F17 | MBD3L3 | A6NE82 | 507 |
| OR4F17 | MBD3L5 | A6NJ08 | 475 |
| OR4F17 | CLEC18B | Q6UXF7 | 473 |
| OR4F17 | ZNF557 | Q8N988 | 471 |
| OR4F17 | MIER2 | Q8N344 | 447 |
| OR4F17 | PLEKHN1 | Q494U1 | 447 |
| OR4F17 | FAM72B | Q86X60 | 435 |
| OR4F17 | NBPF15 | Q8N660 | 417 |
| OR4F17 | SAMD11 | Q96NU1 | 373 |
| OR4F17 | UGT2B17 | O75795 | 370 |
| OR4F17 | MBD3L2 | Q8NHZ7 | 348 |
| OR4F17 | UGT2B28 | Q9BY64 | 321 |
| OR4F17 | GUCY1A2 | P33402 | 313 |
IntAct
0 interactions, top by confidence:
BioGRID (2): OR4F17 (Negative Genetic), OR4F17 (Negative Genetic)
ESM2 similar proteins: A0A096LPK9, A0A0X1KG70, A6NHA9, A6NMZ5, P0C604, P0C623, P0C645, P0DN82, P58180, P58182, Q15615, Q60881, Q6IF82, Q8IXE1, Q8N0Y3, Q8NGA8, Q8NGB4, Q8NGB6, Q8NGC2, Q8NGC3, Q8NGD0, Q8NGD1, Q8NGD2, Q8NGD5, Q8NGE8, Q8NGF4, Q8NGF8, Q8NGF9, Q8NGI4, Q8NGI6, Q8NGJ0, Q8NGJ1, Q8NGL6, Q8NGM1, Q8NGN0, Q8NGN8, Q8NGX5, Q8NH05, Q8NH42, Q8NH49
Diamond homologs: A0A096LPK9, A0A0X1KG70, A6NHA9, A6NMZ5, O60412, O76099, O95013, P0C604, P0C623, P0C645, P0DN82, P23270, P23275, P58173, P58180, P58182, Q15615, Q60878, Q60881, Q60888, Q6IEV9, Q6IEY1, Q6IF82, Q7TQQ0, Q8IXE1, Q8N0Y3, Q8N628, Q8NGA8, Q8NGB2, Q8NGB4, Q8NGB6, Q8NGB8, Q8NGB9, Q8NGC2, Q8NGC3, Q8NGC4, Q8NGC6, Q8NGD0, Q8NGD1, Q8NGD2
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
57 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 44 |
| Likely benign | 7 |
| Benign | 6 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
83 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:110620:TCAA:T | acceptor_loss | 0.9900 |
| 19:110621:CAAG:C | acceptor_loss | 0.9900 |
| 19:110622:AAGGT:A | acceptor_loss | 0.9900 |
| 19:110623:A:G | acceptor_gain | 0.9900 |
| 19:110623:AGGTA:A | acceptor_loss | 0.9900 |
| 19:110622:A:AG | acceptor_gain | 0.9800 |
| 19:110622:AAG:A | acceptor_gain | 0.9800 |
| 19:110624:G:GG | acceptor_gain | 0.9600 |
| 19:110624:GGTAA:G | acceptor_gain | 0.9600 |
| 19:110621:CAAGG:C | acceptor_gain | 0.9300 |
| 19:110624:GGTA:G | acceptor_gain | 0.9300 |
| 19:110620:TCAAG:T | acceptor_gain | 0.9200 |
| 19:110624:GGT:G | acceptor_gain | 0.9200 |
| 19:110622:AAGG:A | acceptor_gain | 0.9000 |
| 19:110623:AG:A | acceptor_gain | 0.8700 |
| 19:110623:AGGT:A | acceptor_gain | 0.8700 |
| 19:110624:GG:G | acceptor_gain | 0.8700 |
| 19:110627:A:AG | acceptor_gain | 0.8700 |
| 19:110624:G:T | acceptor_gain | 0.7700 |
| 19:110619:TTCAA:T | acceptor_gain | 0.7400 |
| 19:107551:TAAAG:T | donor_loss | 0.7200 |
| 19:107552:AAAGG:A | donor_loss | 0.7200 |
| 19:107553:AAG:A | donor_loss | 0.7200 |
| 19:107554:AGG:A | donor_loss | 0.7200 |
| 19:107555:G:GC | donor_loss | 0.7200 |
| 19:107556:G:GA | donor_loss | 0.7200 |
| 19:107557:T:A | donor_loss | 0.7200 |
| 19:107531:TTTG:T | donor_gain | 0.6800 |
| 19:107732:GACA:G | donor_gain | 0.6300 |
| 19:107558:A:C | donor_loss | 0.6200 |
AlphaMissense
2016 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:110691:T:C | F5L | 0.962 |
| 19:110693:C:A | F5L | 0.962 |
| 19:110693:C:G | F5L | 0.962 |
| 19:111183:A:C | S169R | 0.952 |
| 19:111185:T:A | S169R | 0.952 |
| 19:111185:T:G | S169R | 0.952 |
| 19:110692:T:C | F5S | 0.947 |
| 19:111159:T:C | F161L | 0.944 |
| 19:111161:C:A | F161L | 0.944 |
| 19:111161:C:G | F161L | 0.944 |
| 19:111129:A:C | S151R | 0.930 |
| 19:111131:C:A | S151R | 0.930 |
| 19:111131:C:G | S151R | 0.930 |
| 19:111186:T:C | F170L | 0.929 |
| 19:111188:T:A | F170L | 0.929 |
| 19:111188:T:G | F170L | 0.929 |
| 19:111408:T:C | F244L | 0.924 |
| 19:111410:T:A | F244L | 0.924 |
| 19:111410:T:G | F244L | 0.924 |
| 19:110692:T:G | F5C | 0.917 |
| 19:111264:A:C | S196R | 0.909 |
| 19:111266:T:A | S196R | 0.909 |
| 19:111266:T:G | S196R | 0.909 |
| 19:110985:A:C | S103R | 0.904 |
| 19:110987:T:A | S103R | 0.904 |
| 19:110987:T:G | S103R | 0.904 |
| 19:111405:T:C | F243L | 0.899 |
| 19:111407:C:A | F243L | 0.899 |
| 19:111407:C:G | F243L | 0.899 |
| 19:111160:T:G | F161C | 0.898 |
dbSNP variants (sampled 300 via entrez): RS1000965221 (19:108647 A>G), RS1001058580 (19:109405 T>C), RS1004862250 (19:113522 A>C), RS1005836534 (19:106420 T>A,C), RS1008387607 (19:108547 T>A,C), RS1008835036 (19:107573 A>C,G), RS1008898598 (19:109278 C>A), RS1012216973 (19:109682 A>C,G), RS1012766177 (19:111762 G>A), RS1014789917 (19:113543 G>A), RS1014820937 (19:110002 T>C,G), RS1015892582 (19:106510 G>C), RS1021035365 (19:107626 G>A), RS1021140973 (19:108564 C>G,T), RS1024945336 (19:111792 G>A,T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
3 total (human), top 3 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| 2-palmitoylglycerol | increases expression | 1 |
| Niclosamide | decreases expression | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.